Cellular therapy in musculoskeletal tissue regeneration: Perspectives on osteoarthritis and the use of mesenchymal stem cells

Authors

DOI:

https://doi.org/10.33448/rsd-v13i4.45652

Keywords:

Osteoarthritis; Cellular therapy; Mesenchymal stem cells; Tissue regeneration; Joint inflammation.

Abstract

Osteoarthritis is a common and debilitating musculoskeletal condition that causes progressive degeneration of joint cartilage, resulting in pain, stiffness, and limited joint mobility. Faced with the challenges of effective osteoarthritis treatment, cellular therapy has emerged as a promising approach to promote regeneration of affected tissues. This study presents a comprehensive review of cellular therapy in osteoarthritis, highlighting key findings, challenges, and future perspectives in this area. The research was conducted through the selection and analysis of relevant studies in the PubMed, Scopus, and Web of Science databases, with a 20-year inclusion period. Primary studies were prioritized, including clinical trials, meta-analyses, randomized clinical trials, and systematic reviews. The results indicate that cellular therapy, especially the use of mesenchymal stem cells, holds potential to promote cartilage regeneration, reduce inflammation, and modulate the immune response in joints affected by osteoarthritis. However, further research is needed to optimize therapeutic strategies, overcome technical and regulatory challenges, and validate the long-term efficacy and safety of these treatments.

References

Alcaraz, M. J. (2024). Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis. Biochem Pharmacol. Advance online publication. https://doi.org/10.1016/j.bcp.2024.116226

Altomare, D., Di Matteo, B., & Kon, E. (2024). Conservative Treatment for Ankle Cartilage: Cellular and Acellular Therapies: A Systematic Review. Foot Ankle Clin, 29(2), 253-263. https://doi.org/10.1016/j.fcl.2023.07.003

Bari, E., Perteghella, S., Di Silvestre, D., Sorlini, M., Catenacci, L., & Sorrenti, M. (2018). Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy. Nanomedicine, 13(7), 777-89.

Blanco, F. J., Guitian, R., Vázquez-Martul, E., de Toro, F. J., & Galdo, F. (2011). Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis research & therapy, 3(5), 1-7.

Burr, D. B., & Gallant, M. A. (2012). Bone remodelling in osteoarthritis. Nature Reviews Rheumatology, 8(11), 665-673.

Chahal, J., Gómez-Aristizábal, A., Shestopaloff, K., Bhatt, S., Chaboureau, A., Fazio, A., ... & Lattermann, C. (2019). Bone marrow mesenchymal stromal cell treatment in patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation. Stem Cells Translational Medicine, 8(8), 746-757.

Dai, W. L., Zhou, A. G., Zhang, H., Zhang, J., & Min, J. K. (2017). Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduction and Targeted Therapy, 2, 17023.

Di Matteo, B., Vandenbulcke, F., Vitale, N. D., Lenaerts, C., Gabay, O., & Deroanne, C. F. (2018). A novel stem cell 3D culture system to study osteoarthritis. Journal of Orthopaedic Research, 36(5), 1615-1625.

Fellows, C. R., Matta, C., Zakany, R., Khan, I. M., & Mobasheri, A. (2016). Adipose, bone marrow and synovial joint-derived mesenchymal stem cells for cartilage repair. Frontiers in Genetics, 7, 213.

Felson, D. T. (2013). Osteoarthritis of the knee. New England Journal of Medicine, 354(8), 841-848.

Gjerde, C., Mustafa, K., Hellem, S., Rojewski, M. T., & Gjengedal, H. (2020). Regulation of bone marrow-derived mesenchymal stromal cell-based products for use in osteoarthritis treatment. Tissue Engineering Part B: Reviews, 26(3), 193-201.

Goldring, M. B., & Goldring, S. R. (2016). Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Annals of the New York Academy of Sciences, 1192(1), 230-237.

Huey, D. J., & Hu, J. C. (2015). Athanasiou. FASEB Journal, 29(5), 1914-1925.

Hunter, D. J., & Felson, D. T. (2009). Osteoarthritis. British Medical Journal, 338, b3056.

Liu, X., Ni, M., Huang, Y., Zhang, J., Yao, H., & Wei, Z. (2019). Therapeutic effect of human umbilical cord mesenchymal stem cells at various passages on acute lung injury in mice. American Journal of Translational Research, 11(12), 7447–7457.

Loeser, R. F., Goldring, S. R., Scanzello, C. R., & Goldring, M. B. (2012). Osteoarthritis: a disease of the joint as an organ. Arthritis & Rheumatism, 64(6), 1697-1707.

Loibl, M., Lang, S., Brockhoff, G., Groll, J., & Huber, M. (2020). Cartilage regeneration and inflammation modulation in knee osteoarthritis following injection of allogeneic adipose-derived mesenchymal stromal cells: a phase II, triple-blinded, placebo-controlled, randomized trial.

Martel-Pelletier, J., Barr, A. J., Cicuttini, F. M., Conaghan, P. G., Cooper, C., Goldring, M. B., ... & Pelletier, J. P. (2016). Osteoarthritis. Nature Reviews Disease Primers, 2(1), 1-21.

Mobasheri, A., Rayman, M. P., & Gualillo, O. (2014). Identification of New Therapeutic Targets for Osteoarthritis through Genome-Wide Analyses of UK Biobank Data. Biochemical and Biophysical Research Communications, 455(3–4), 340–345.

Scanzello, C. R., & Goldring, S. R. (2012). The role of synovitis in osteoarthritis pathogenesis. Bone, 51(2), 249-257.

Sellam, J., & Berenbaum, F. (2010). The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nature Reviews Rheumatology, 6(11), 625-635.

Vázquez-Portalatín, N., Kilroy, G., Johnson, C., Lyles, C. B., & Von Kossa, C. (2019). A comparison of hyaluronic acid and methylene blue/red light cross-linking, mesenchymal stem cell therapy, and osteoarthritis curettage in an osteoarthritis goat model. Journal of Orthopaedic Surgery and Research, 14(1), 1-9.

Viganò, M., Sansone, V., d'Agostino, M. C., Romeo, P., Perucca Orfei, C., De Girolamo, L., & Domenicucci, M. (2016). Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders. Journal of Orthopaedic Surgery and Research, 11(1), 1-11.

Wang, Y., Yuan, M., Guo, Q. Y., & Lu, S. B. (2019). Clinical efficacy of stem cell therapy for osteoarthritis: a meta-analysis. Clinical Orthopaedics and Related Research®, 477(5), 1070-1083.

Wang, Y., Yu, D., Liu, Z., Zhou, F., Dai, J., Wu, B., ... & Zhang, H. (2013). Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Research & Therapy, 4(5), 1-13.

Wen, S., Huang, X., Ma, J., Zhao, G., Ma, T., Chen, K., ... Wang, S. (2024). Exosomes derived from MSC as drug system in osteoarthritis therapy. Front Bioeng Biotechnol, 12:1331218. https://doi.org/10.3389/fbioe.2024.1331218

Xie, R. H., Gong, S. G., Song, J., Wu, P. P., & Hu, W. L. (2024). Effect of mesenchymal stromal cells transplantation on the outcomes of patients with knee osteoarthritis: A systematic review and meta-analysis. Journal of Orthopaedic Research, 42(4), 753-768. https://doi.org/10.1002/jor.25724

Zhang, S., Chu, W. C., Lai, R. C., Lim, S. K., & Hui, J. H. (2018). Toh WS. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis and Cartilage, 26(11), 1414-1425.

Downloads

Published

30/04/2024

How to Cite

SANTOS, L. H. C. dos .; LIMA, M. J. de C. .; VALENÇA, A. L.; JORDÃO, L. de A. C. .; DINIZ, Y. J. V. .; STAMFORD, S. de F.; FERREIRA, A. P. V. S.; FERREIRA, M. C. P. V. .; FERREIRA, I. B. .; FRANÇA , L. A. S. de .; COUTO, V. C. S. . Cellular therapy in musculoskeletal tissue regeneration: Perspectives on osteoarthritis and the use of mesenchymal stem cells. Research, Society and Development, [S. l.], v. 13, n. 4, p. e12213445652, 2024. DOI: 10.33448/rsd-v13i4.45652. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/45652. Acesso em: 21 nov. 2024.

Issue

Vol. 13 No. 4

Section

Health Sciences

License

Copyright (c) 2024 Luiz Henrique Cunha dos Santos; Márcio José de Carvalho Lima; Alice Lopes Valença; Layla de Albuquerque Campos Jordão; Yale Janguiê Valgueiro Diniz; Sabrina de Freitas Stamford; Adriana Parente Vianna Simões Ferreira; Mariana Cavalcanti Pirajá Viana Ferreira; Isabela Bonfim Ferreira; Lais Araújo Silva de França ; Victoria Carolyna Silva Couto

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.